Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
09/16/1990 | WO1990010445A1 Therapeutic agents |
09/16/1990 | CA2049980A1 Therapeutic agents |
09/16/1990 | CA2012126A1 Pharmaceutical composition with a positively inotropic activity, containing a synergistically acting mixture consisting of a benzimidazole and a ss-blocker, the preparation and use thereof |
09/12/1990 | EP0386563A1 Antisense-oligonucleotides for inhibiting the transactivator target sequence (TAR) and the synthesis of the transactivator protein (Tat) of HIV-I, and their use |
09/12/1990 | EP0386117A1 Treating premenstrual or late luteal phase syndrome |
09/11/1990 | WO1990010462A1 Combination therapy for treatment of estrogen sensitive diseases |
09/11/1990 | US4956355 Ketosteroids for viral infections |
09/07/1990 | WO1990009789A2 Pharmaceutically active agents that impede amyloid formation in vivo |
09/05/1990 | EP0385859A1 Composition for enhancing cancer therapy by administration of unsaturated fatty acids |
09/05/1990 | EP0246439B1 Sterile plasma substitute |
09/04/1990 | CA1273575A1 Pharmaceutical compositions consisting of acylated phospholipids |
09/01/1990 | CA2010511A1 Method of enhancing cancer therapy by administration of unsaturated fatty acids |
08/29/1990 | EP0384421A2 Use of PAF antagonists in the treatment of pathologic changes of the blood gas |
08/29/1990 | EP0383919A1 Staurosporin derivatives |
08/29/1990 | EP0158249B1 Medicinal oil bath |
08/28/1990 | US4952567 Administering a protein kinase antagonist |
08/28/1990 | US4952411 Using mixture of silver salt and a biquanide |
08/23/1990 | WO1990009192A1 Inhibiting transformation of cells having elevated purine metabolic enzyme activity |
08/23/1990 | WO1990009182A1 Pharmaceutical and veterinary compositions for the treatment or prevention of helminthiasis |
08/23/1990 | WO1990009171A1 Cardio-protective drug preparations comprising amiodarone, a nitrate derivate, in particular isosorbide dinitrate and optionally a beta-blocker |
08/23/1990 | CA2010600A1 Use of paf-antagonists for treating pathological changes in blood gas |
08/21/1990 | CA1272955A1 Pharmaceutical composition containing an analgesic and an antiinflammatory agent |
08/16/1990 | EP0382619A1 Process for producing foams for cosmetical and pharmaceutical use, and foams obtained by this process |
08/16/1990 | EP0382582A1 Tetra-aza macrocyles and processes for their preparation |
08/16/1990 | EP0382411A2 Delivery of cytotoxic agents |
08/16/1990 | EP0381763A1 Antibody modified with toxin |
08/14/1990 | US4948803 Using azabicycloindazole-3-carboxamides |
08/11/1990 | WO1990009388A1 Tetra-aza macrocycles and processes for their preparation |
08/11/1990 | CA2026322A1 Tetra-aza macrocycles and processes for their preparation |
08/09/1990 | DE4003392A1 Thromboxan a(pfeil abwaerts)2(pfeil abwaerts)-rezeptor-antagonisten zur verwendung bei der behandlung von bluthochdruck Thromboxane A (down arrow) 2 (down arrow) receptor antagonists for use in the treatment of high blood pressure |
08/09/1990 | CA2009607A1 Process for the production of cosmetic and pharmaceutical foams and foams thus produced |
08/08/1990 | EP0381446A1 Oral antifungal compositions |
08/08/1990 | EP0381414A2 Anti-ulcer composition |
08/08/1990 | EP0381075A2 Method for treating addiction to a drug of abuse employing an ace inhibitor |
08/08/1990 | EP0381074A2 Method for facilitating dieting employing an ACE inhibitor |
08/07/1990 | US4946675 Hepatic blocking agents |
08/06/1990 | CA2007896A1 Method of treating hypertension using a thromboxane a2 receptor antagonist and new combinations |
08/02/1990 | DE4002836A1 Arzneistoffkombination aus einem hmg coa-reduktase-inhibitor und einem squalen-synthetase-inhibitor zur verwendung bei der senkung des serum-cholesterinspiegels und/oder zur vorbeugung oder behandlung von arteriosklerose Drug combination of a HMG CoA reductase inhibitor and a squalene synthetase inhibitor, for use in lowering serum cholesterol levels and / or for the prevention or treatment of arteriosclerosis |
08/02/1990 | DE4002825A1 Arzneistoffkombination aus einem squalen-synthetase-inhibitor und einem anderen, das serum-cholesterin absenkenden wirkstoff Drug combination of a squalene synthetase inhibitor and another, the serum cholesterol-lowering drug |
08/02/1990 | CA2009071A1 Delivery of cytotoxic agents |
08/01/1990 | EP0380370A2 Inhibiting tumour recurrence after surgical resection |
08/01/1990 | EP0379933A2 Surface treatment system containing an antineoplastic agent, particularly 5-fluor uracil |
08/01/1990 | CA2007643A1 Combination of an hmg coa reductase inhibitor and a squalene synthetase inhibitor and method for lowering serum cholesterol using such combination |
08/01/1990 | CA2007641A1 Combination of squalene synthetase inhibitor and other type of serum cholesterol reducing agent and method for lowering serum cholesterol using such combination |
07/31/1990 | US4944943 Mixture of a substance having thrombolytic activity and of an antithrombotic substance |
07/31/1990 | US4944941 Surfactants |
07/30/1990 | CA2007525A1 Method for facilating dieting employing an ace inhibitor |
07/30/1990 | CA2007524A1 Method for treating addiction to a drug of abuse employing an ace inhibitor |
07/26/1990 | WO1990007952A1 Treatment methods and vaccines |
07/26/1990 | WO1990007929A1 Site specific in-vivo activation of therapeutic drugs |
07/26/1990 | WO1990007876A1 Biological fluids purification systems |
07/26/1990 | CA2008534A1 Method for inhibiting tumor recurrence after surgical resection |
07/25/1990 | EP0378676A1 Tumor necrosis enhancing factor and methods of preparation and use |
07/25/1990 | EP0378643A1 Combinations of soluble t4 proteins and anti-retroviral agents and methods for treating or preventing aids, arc and hiv infection |
07/25/1990 | EP0378621A1 Diagnostics and therapy for rheumatoid arthritis |
07/24/1990 | CA2025899A1 Site specific in-vivo activation of therapeutic drugs |
07/21/1990 | WO1990007932A1 Fibrinolysis |
07/21/1990 | CA2045574A1 Fibrinolysis |
07/20/1990 | CA2025662A1 Blood purification system |
07/18/1990 | EP0377657A1 Human ovarian tumor-associated antigen specific for monoclonal antibody ov-tl3 |
07/18/1990 | EP0377583A1 Proteinase inhibitors for treatment of gastrointestinal ulcer disease |
07/17/1990 | US4942170 2-(substituted methylidene)-N-[3-[piperidin-1-yl]propyl]hydrazine carboximidamides useful as antiparasitics |
07/17/1990 | US4942161 Adrenergic blocking agents for vision defects |
07/17/1990 | US4942040 Controlled and extended release agents for delivery of drugs of dihydropyridines or adrenoreceptor antagonist such as metoprolol |
07/14/1990 | WO1990008315A1 Composition and method for treatment of senile dementia |
07/14/1990 | CA2046328A1 Composition and method for the treatment of senile dementia |
07/12/1990 | WO1990007792A1 Method of making high density solder bumps and a substrate socket for high density solder bumps |
07/12/1990 | WO1990007572A1 HUMAN DNase |
07/12/1990 | WO1990007336A1 Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids |
07/11/1990 | EP0377518A2 Sustained release pharmaceutical composition |
07/11/1990 | EP0376999A1 Method of reversing the side effects of epidural analgesics |
07/11/1990 | EP0376986A1 Chemical splinter removal |
07/10/1990 | US4940719 Tetrahydrocarbazole esters, pharmaceutical compositions and use |
07/10/1990 | CA1271421A1 Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics |
07/04/1990 | WO1990007343A1 Liquid orally administrable compositions based on edible oils |
07/04/1990 | EP0272177B1 Pharmaceutical composition containing diltiazem and an inhibitor of the enzyme-transforming angiotensin |
07/04/1990 | CN1043442A Method of potentiating immune response and compositions therefor |
07/04/1990 | CA2045488A1 Liquid orally administrable compositions based on edible oils |
07/03/1990 | US4938984 Nutritive compositions containing fatty substances |
07/03/1990 | US4938949 Combatting side effects of anticancer drugs with dithiocarbamates |
06/28/1990 | WO1990006774A1 Hindered linking agents and methods |
06/28/1990 | WO1990006748A2 Use of certain herbicides in cancer treatment and production of protoporphyrin ix |
06/28/1990 | WO1990004387A3 Compositions for treating tobacco withdrawal symptoms |
06/27/1990 | EP0375562A2 Novel monoclonal antibody to human carcinomas |
06/27/1990 | EP0375319A2 Angiotensin converting enzyme inhibitors in the treatment of glaucoma |
06/27/1990 | EP0375156A2 Plasma cholesterol level lowering medicaments |
06/27/1990 | EP0374510A1 Products for the treatment of endotoxic shock in a mammal |
06/27/1990 | EP0374267A1 Derivatives of platinum (p) with a polyanion of deoxyribonucleic acid, method for obtaining them and pharmaceutical antitumor preparation based on them |
06/27/1990 | EP0374218A1 Novel transdermal penetration enhancers |
06/27/1990 | EP0374207A1 Drug for treating cancer, aids and viral diseases |
06/26/1990 | CA1270761A1 Preparation of a composition based on a finely divided active principle of low water solubility |
06/22/1990 | CA2006629A1 Hindered linking agents and methods |
06/22/1990 | CA2006353A1 Monoclonal antibody to human carcinomas |
06/20/1990 | EP0374096A1 Combination therapy involving 2',3'-dideoxypurine nucleoside and an inhibitor of purine nucleoside phosphorylase, and its compositions |
06/20/1990 | EP0373904A1 Process and composition for increasing brain dopamine release |
06/19/1990 | CA2005753A1 Angiotensin converting enzyme inhibitors in the treatment of glaucoma |
06/19/1990 | CA2005670A1 Method for treatment of endotoxic shock in a mammal |
06/14/1990 | WO1990006136A1 Fast buccal tablet |
06/14/1990 | WO1990006109A1 Adhesion of mycoplasma pneumoniae and mycoplasma hominus to sulfatide |
06/14/1990 | WO1990003798A3 Targetting agents |